Cancer risk among lung transplant recipients with cystic fibrosis
- PMID: 27539828
- PMCID: PMC7296446
- DOI: 10.1016/j.jcf.2016.07.011
Cancer risk among lung transplant recipients with cystic fibrosis
Abstract
Background: Previous studies demonstrated increased digestive tract cancers among individuals with cystic fibrosis (CF), particularly among lung transplant recipients. We describe cancer incidence among CF and non-CF lung recipients.
Methods: We used data from the US transplant registry and 16 cancer registries. Standardized incidence ratios (SIRs) compared cancer incidence to the general population, and competing risk methods were used for the cumulative incidence of colorectal cancer.
Results: We evaluated 10,179 lung recipients (1681 with CF). Risk was more strongly increased in CF recipients than non-CF recipients for overall cancer (SIR 9.9 vs. 2.7) and multiple cancers including colorectal cancer (24.2 vs. 1.7), esophageal cancer (56.3 vs. 1.3), and non-Hodgkin lymphoma (61.8 vs. 9.4). At five years post-transplant, colorectal cancer was diagnosed in 0.3% of CF recipients aged <50 at transplant and 6.4% aged ≥50.
Conclusions: CF recipients have increased risk for colorectal cancer, suggesting a need for enhanced screening.
Keywords: Cancer; Transplant.
Copyright © 2016 European Cystic Fibrosis Society. All rights reserved.
Figures



References
-
- Foundation CF. Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation, 2014.
-
- McIntosh JC, Schoumacher RA, Tiller RE. Pancreatic adenocarcinoma in a patient with cystic fibrosis. The American journal of medicine. 1988;85(4):592. - PubMed
-
- Tedesco FJ, Brown R, Schuman BM. Pancreatic carcinoma in a patient with cystic fibrosis. Gastrointestinal endoscopy. 1986;32(1):25–6. - PubMed
-
- Roberts JA, Tullett WM, Thomas JS, Galloway D, Stack BH. Bowel adenocarcinoma in a patient with cystic fibrosis. Scottish medical journal. 1986;31(2):109. - PubMed
Publication types
MeSH terms
Grants and funding
- U58 DP003931/DP/NCCDPHP CDC HHS/United States
- HHSN261201000037C/CA/NCI NIH HHS/United States
- U58 DP003875/DP/NCCDPHP CDC HHS/United States
- N01 PC035139/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- HHSN261201300071C/CA/NCI NIH HHS/United States
- U58 DP003920/DP/NCCDPHP CDC HHS/United States
- N01 PC035142/CA/NCI NIH HHS/United States
- HHSN261201200017I/CA/NCI NIH HHS/United States
- HHSN261201200021I/CP/NCI NIH HHS/United States
- U58 DP000832/DP/NCCDPHP CDC HHS/United States
- U58 DP000824/DP/NCCDPHP CDC HHS/United States
- U58 DP003883/DP/NCCDPHP CDC HHS/United States
- N01 PC035143/CA/NCI NIH HHS/United States
- HHSN261201000035C/CA/NCI NIH HHS/United States
- HHSN261201000036C/CA/NCI NIH HHS/United States
- U58 DP003879/DP/NCCDPHP CDC HHS/United States
- HHSN261201300011C/RC/CCR NIH HHS/United States
- U58 DP000807/DP/NCCDPHP CDC HHS/United States
- HHSN261201300021C/CA/NCI NIH HHS/United States
- HHSN261201000035I/CA/NCI NIH HHS/United States
- U58 DP000848/DP/NCCDPHP CDC HHS/United States
- Z01 CP010150/ImNIH/Intramural NIH HHS/United States
- HHSN261201000024C/CA/NCI NIH HHS/United States
- HHSN261201000034C/CA/NCI NIH HHS/United States
- U58 DP003921/DP/NCCDPHP CDC HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical